Endocrine treatment of breast cancer: effects upon intratumoral estrone sulfate metabolism and peripheral steroid levels.
D000616:Aminoglutethimide / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D003613:Danazol / Q000627:therapeutic use*; D003687:Dehydroepiandrosterone / Q000031:analogs & derivatives / Q000097:blood; D019314:Dehydroepiandrosterone Sulfate; D004334:Drug Administration Schedule; D004967:Estrogens / Q000097:blood; D004970:Estrone / Q000031:analogs & derivatives / Q000378:metabolism; D005260:Female; D006801:Humans; D011245:Pregnadienes / Q000627:therapeutic use*; D012738:Sex Hormone-Binding Globulin / Q000097:blood; D013629:Tamoxifen / Q000627:therapeutic use*
D004967:Estrogens; D011245:Pregnadienes; D012738:Sex Hormone-Binding Globulin; D013629:Tamoxifen; D000616:Aminoglutethimide; D004970:Estrone; D003687:Dehydroepiandrosterone; D019314:Dehydroepiandrosterone Sulfate; D003613:Danazol; C017296:estrone sulfate